Prolife PX7 Premium — The First in the World Home BPM Validated in the EU Under the Latest ISO Standard

Prolife is proud to announce a significant milestone in cardiovascular diagnostics. Prolife PX7 Premium is currently the first in the World Home Blood Pressure Monitor with 22–45 cm cuff validated in the European Union under ISO 81060-2:2018 + AMD1:2020 and AMD2:2024. This validation is independently confirmed by STRIDE BP, the internationally recognized platform for clinically validated blood pressure devices.

🔗 View listing:

https://www.stridebp.org/device/montex-prolife-px7-premium/

Inclusion on STRIDE BP confirms that PX7 Premium meets internationally accepted clinical accuracy protocols — reinforcing confidence among healthcare professionals, regulatory stakeholders, and distribution partners.

Built on More Than Validation

PX7 Premium combines clinical rigor with intelligent technology integration. The device features:

🔸 AI-powered measurement technology with intelligent adaptation of the measurement process

🔸 Support for detection of AFIB

🔸 Personalized, adaptive measurement cycles designed to improve user comfort

The result is innovation that strengthens clinical confidence — without adding complexity for the user.

As demand for reliable, clinically validated home diagnostics continues to grow, validation under the most recent ISO amendments provides a clear competitive advantage.

At Prolife, we combine innovative engineering, Swiss Quality delivered through Swiss Technology, and internationally recognized clinical validation to create cardiovascular solutions partners can trust, adopt, and scale.

Prolife — Trust the Best.